EFFECT OF INTERFERON THERAPY ON BONE-MARROW MORPHOLOGY IN CHRONIC MYELOID-LEUKEMIA - A CYTOCHEMICAL AND IMMUNOHISTOCHEMICAL STUDY OF TREPHINE BIOPSIES

Citation
J. Thiele et al., EFFECT OF INTERFERON THERAPY ON BONE-MARROW MORPHOLOGY IN CHRONIC MYELOID-LEUKEMIA - A CYTOCHEMICAL AND IMMUNOHISTOCHEMICAL STUDY OF TREPHINE BIOPSIES, Journal of interferon & cytokine research, 16(3), 1996, pp. 217-224
Citations number
70
Categorie Soggetti
Biology,Immunology
ISSN journal
10799907
Volume
16
Issue
3
Year of publication
1996
Pages
217 - 224
Database
ISI
SICI code
1079-9907(1996)16:3<217:EOITOB>2.0.ZU;2-U
Abstract
The effect of interferon (IFN) therapy on bone marrow features in chro nic myeloid leukemia (CML) has been studied on successive trephine bio psies (mean interval 13 +/- 8 months) by cytochemical and immunohistoc hemical methods in combination with morphometry and in comparison with a control group of patients who received monotherapy by busulfan (BU) . Following IFN administration (IFN-alpha frequently in combination wi th IFN-gamma), there was a decrease in neutrophil granulopoiesis accom panied by a significant expansion of erythroid precursors and increase d numbers of hemosiderin-laden macrophages. These changes corresponded with the hematologic response in 21 of the 25 patients investigated. Numbers of megakaryocytes and reticulin/collagen fiber density increas ed during treatment. Most conspicuously, in responding patients atypic al micromegakaryocytes, usually characterizing CML, were partially rep laced by normal-sized cells of this lineage. These features are in kee ping with the assumption of a reappearance of the normal hematopoietic cell clone as the result of IFN therapy, which was not found in the B U-treated control group. On the other hand, a relevant subpopulation o f micromegakaryocytes (about 30%) was still maintained. This result pr obably relates to the failure to improve myelofibrosis more effectivel y. Analysis of cell proliferation (proliferating cell nuclear antigen- PCNA) and apoptosis (in situ end labeling) revealed a reduction in PCN A labeling and increased numbers of cells undergoing programmed death, Identification of the activated subset of macrophages (alpha-D-galact osyl residues expression) by appropriate lectin histochemistry disclos ed an increase in the number of GSA-I binding cells. These findings we re exclusively limited to IFN administration and reflect an inhibitory effect of IFN on cell proliferation and stimulation of programmed cel l death. The latter phenomenon probably results in increased phagocyto sis of clonally transformed myeloid cells by GSA-I-positive (activated ) macrophages.